Other on-target/off tumor toxicities after FAP+ stromal cell depletion with CAR-T cells, reported by Roberts et al., were bone marrow hypoplasia, anemia, pancreatic toxicity and loss of muscle mass (175). The gene discussed is FAP; the disease is anemia (phenotype).